Clinical Trial

CMF Bone Stimulation Treatment of Ankle Fractures

Study Description

CMF Bone Stimulation as Adjunct to Surgical Treatment of Ankle Fractures

The OL1000 is intended to be used as a non-invasive adjunctive treatment for adult males or females that have sustained a closed, unstable ankle fracture that requires surgical treatment for stabilization. The initiation of the adjunctive treatment is to begin within 11 days of surgical stabilization.

Location

Locations Selected Location

Methods

No pharmaceutical medication involved No pharmaceutical medication involved
Patients and healthy individuals accepted Patients and healthy individuals accepted

Device - Active Combined Magnetic Field OL1000 Bone Growth Stimulator

Active CMF OL1000 Device

Device - Sham Combined Magnetic Field OL1000 Bone Growth Stimulator

Sham CMF OL1000

Additional Information

Official Study Title

Prospective, Randomized, Double-Blinded, Controlled Multi-Center Clinical Trial Evaluating the Use of Non-Invasive CMF Bone Stimulation as Adjunct to Surgical Treatment of Ankle Fractures

Clinical Trial ID

NCT02688855

ParticipAid ID

mepLye